Science

Suzuki & Citterio Laboratory designs and synthesizes functional dyes that change color or produce light by reacting with a specific substance. It develops nano-sized functional materials such as particles and polymers, and develops sensing technology that utilizes fluorescent and luminescent molecules, providing imaging inside the body which had been impossible until now.
The Nakata-Saikawa Research Lab in the Department of Applied Chemistry at Keio University’s Faculty of Science and Technology has been conducting synthesis research targeting natural organic compounds with complex and unique structures, and has successfully synthesized abundantly varied ansa compounds that cannot be created in the natural world.
Breaking News: Japanese Researchers Win Nobel Prize for Blue LEDs - AkihabaraNews.com

AkihabaraNews Congratulates:
Isamu Akasaki of Meijo University and Nagoya University; Hiroshi Amano of Nagoya University; and Shuji Nakamura of University of California, Santa Barbara for:

The Takao Laboratory of Keio University’s Faculty of Science and Technology Department of Applied Chemistry is engaged in the research and development of artificially creating various organic compounds extracted from natural sources.

In the Department of Applied Chemistry at Keio University's Faculty of Science and Technology, the Katayama Laboratory is doing research in the field of electrochemistry.

One aspect of the Lab's research is investigating electrochemical reactions in electrolytes called ionic liquids, and applying them to technologies, including new batteries and electroplating.

Akihabaranews.com - Honda Motor Europe - ASIMO was promoting science in Slovakia

ASIMO is back again.  He has traveled to Bratislava, Slovakia to attend European Researchers' Night to help give inspiration to the country's next generation of scientists and engineers.

Nikon Business in Health and Medical Investment in Retina Institute Japan, K.K.

Nikon Corporation announced today that it signed an agreement to invest in Retina Institute Japan, K.K. (RIJ).

Under the agreement, Nikon will subscribe for 500 million yen worth of shares issued by RIJ.

Together, Nikon and RIJ will collaborate on developing practical uses of medical treatments for age-related macular degeneration.  RIJ has been working on the world's first case of regenerative medicine using iPS cell technology, utilizing Nikon's own core technology in optics and imaging.